News

Soleno Therapeutics to Participate in the LifeSci Partners 11th Annual Corporate Access Event

January 05, 2022

REDWOOD CITY, Calif. , Jan. 05, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 19, 2021

REDWOOD CITY, Calif. , Nov. 19, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

November 10, 2021

REDWOOD CITY, Calif. , Nov. 10, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage ...

Read More